Syapse has entered into a strategic collaboration with Pfizer to advance cancer outcomes research using real-world evidence. The collaboration will initially focus on the molecular testing and therapy choices on precision oncology in the healthcare system setting. "Pfizer is committed to using real-world evidence to improve cancer care and decision-making by healthcare providers," said Chris Boshoff, M.D., Ph.D., Chief Development Officer, Oncology, Pfizer Global Product Development.